Cargando...
Targeting dormant micrometastases: rationale, evidence to date and clinical implications
In spite of decades of research, cancer survival has increased only modestly. This is because most research is based on models of primary tumors. Slow recognition has begun that disseminated, dormant cancer cells (micrometastatic cells) that are generally resistant to chemotherapy are the culprits i...
Gardado en:
| Publicado en: | Ther Adv Med Oncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SAGE Publications
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4753353/ https://ncbi.nlm.nih.gov/pubmed/26929788 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834015624277 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|